BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23954287)

  • 1. E2F1 activates p53 transcription through its distal site and participates in apoptosis induction in HPV-positive cells.
    Massip A; Arcondéguy T; Touriol C; Basset C; Prats H; Lacazette E
    FEBS Lett; 2013 Oct; 587(19):3188-94. PubMed ID: 23954287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
    Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of E1AF as a target gene of E2F1-induced apoptosis in response to DNA damage.
    Wei Y; Liu D; Ge Y; Zhou F; Xu J; Chen H; Gu J; Jiang J
    J Biochem; 2008 Oct; 144(4):539-46. PubMed ID: 18687701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jab1 is a specificity factor for E2F1-induced apoptosis.
    Hallstrom TC; Nevins JR
    Genes Dev; 2006 Mar; 20(5):613-23. PubMed ID: 16481464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
    Choi M; Lee H; Rho HM
    IUBMB Life; 2002 Jun; 53(6):309-17. PubMed ID: 12625370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R; Ma Y; Song L; Haura EB; Cress WD
    Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation.
    Gurtner A; Fuschi P; Martelli F; Manni I; Artuso S; Simonte G; Ambrosino V; Antonini A; Folgiero V; Falcioni R; Sacchi A; Piaggio G
    Cancer Res; 2010 Dec; 70(23):9711-20. PubMed ID: 20952509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Baptiste N; Friedlander P; Chen X; Prives C
    Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the MDR1 promoter by E2F1 and EAPP.
    Andorfer P; Rotheneder H
    FEBS Lett; 2013 May; 587(10):1504-9. PubMed ID: 23542036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter.
    Ayrault O; Andrique L; Séité P
    Exp Cell Res; 2006 Apr; 312(7):1185-93. PubMed ID: 16510138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.
    Lin WC; Lin FT; Nevins JR
    Genes Dev; 2001 Jul; 15(14):1833-44. PubMed ID: 11459832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
    Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J
    Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.